4basebio synthetic DNA used in Phase I/II mRNA therapy trial

Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis

Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio

Merck KGaA to acquire JSR Life Sciences chromatography business to expand Protein A capabilities

60 Degrees reports first patient has tested negative for babesiosis in tafenoquine study

INOVIO announces inducement grant to new employee

Hologic receives FDA clearance and CE mark for new gastrointestinal bacterial assays

Appili Therapeutics and Vitalex Biosciences secure NIAID contract for fungal vaccine development for up to USD40m

LakeShore Biopharma receives Nasdaq delisting determination letter

CorMedix to acquire Melinta Therapeutics in USD300m deal to expand infectious disease portfolio

INOVIO to release Q2 2025 financial results on 12 August

Bavarian Nordic chikungunya vaccine enters Health Canada review process

Ondine Biomedical completes world-first ICU study with Steriwave nasal therapy

Senhwa Biosciences reports first patient dosed in Pidnarulex (CX-5461) study in patients with advanced solid tumours

Centivax raises USD45m to commercialise universal flu vaccine